CIK 0000914475
- Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330525145
- Phone
- +1 858-617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Sale | −22,162 | $125.90 | $2.8M | 15,643 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Option exercise | +7,775 | $35.99 | $280K | 23,418 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Sale | −7,775 | $125.90 | $979K | 15,643 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Option exercise | +20,063 | $43.24 | $868K | 35,706 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Sale | −20,063 | $125.90 | $2.5M | 15,643 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option | −22,162 | $41.78 | $926K | 0 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option | −7,775 | $35.99 | $280K | 0 |
| 2022-11-30 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option | −20,063 | $43.24 | $868K | 53,543 |
| 2022-11-29 | Onyia Jude Chief Scientific Officer | Sale | −2,331 | $121.90 | $284K | 2,366 |
| 2022-11-10 | BENEVICH ERIC Chief Commercial Officer | Option exercise | +100 | $41.78 | $4K | 15,743 |
| 2022-11-10 | BENEVICH ERIC Chief Commercial Officer | Sale | −100 | $125.36 | $13K | 15,643 |
| 2022-11-10 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option | −100 | $41.78 | $4K | 22,162 |
| 2022-11-08 | BENEVICH ERIC Chief Commercial Officer | Option exercise | +24,593 | $41.78 | $1.0M | 40,236 |
| 2022-11-08 | BENEVICH ERIC Chief Commercial Officer | Sale | −24,593 | $125.33 | $3.1M | 15,643 |
| 2022-11-08 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Non-Qualified Stock Option | −24,593 | $41.78 | $1.0M | 22,262 |
| 2022-11-08 | Lippoldt Darin Chief Legal Officer | Option exercise | +5,082 | $43.24 | $220K | 34,316 |
| 2022-11-08 | Lippoldt Darin Chief Legal Officer | Sale | −5,082 | $125.04 | $635K | 29,234 |
| 2022-11-08 | Lippoldt Darin Chief Legal Officer | Option exercise · Non-Qualified Stock Option | −5,082 | $43.24 | $220K | 25,206 |
| 2022-11-08 | Cooke Julie Chief Human Resources Officer | Option exercise | +5,592 | $81.05 | $453K | 20,694 |
| 2022-11-08 | Cooke Julie Chief Human Resources Officer | Sale | −5,592 | $124.99 | $699K | 15,102 |
Page 50 of 62 · 1,221 trades